Occudo Quantitative Strategies LP Innoviva, Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $1.22 Million - $1.61 Million	98,682 New	98,682 $1.58 Million
Q4 2022 Feb 14, 2023	SELL	$11.8 - $13.78 $585,409 - $683,639	-49,611 Reduced 46.87%	56,243 $745,000
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $984,365 - $1.29 Million	84,786 Added 402.44%	105,854 $1.23 Million
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $236,108 - $327,781	-16,488 Reduced 43.9%	21,068 $311,000
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $577,986 - $760,509	37,556 New	37,556 $727,000

227

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.23B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.